ACXP vs CRL · $11.3M cap vs rev $2.00B
Acurx Pharmaceuticals LLC (ACXP) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
ACXP does not have a complete income-statement cache yet.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
ACXP currently screens at market cap $11.3M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the ACXP and CRL stock pages for the full models.
Not investment advice.